U.S. Markets closed

Intercept Pharmaceuticals, Inc. (ICPT)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
130.57+2.17 (+1.69%)
At close: 4:00PM EDT

130.57 0.00 (0.00%)
After hours: 4:34PM EDT

People also watch
PBYICLVSKITESRPTBLUE
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue24,9512,7821,742
Cost of Revenue---
Gross Profit24,9512,7821,742
Operating Expenses
Research Development153,893112,69680,311
Selling General and Administrative273,596119,24234,601
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-402,538-229,156-113,170
Income from Continuing Operations
Total Other Income/Expenses Net3,9042,727-170,056
Earnings Before Interest and Taxes-398,634-226,429-283,226
Interest Expense14,19614,19614,196
Income Before Tax-412,830-226,429-283,226
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-412,830-226,429-283,226
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-412,830-226,429-283,226
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-412,830-226,429-283,226